Developer docs
API playgroundTry for free, no card

Search company profiles

CCRM Nordic

Full company profile

uuid028r2j8

Namestring
CCRM Nordic
Websiteurl
ccrmnordic.se
Company typeenum
Private
Founded yearint
2023
Descriptiontext

CCRM Nordic is a Sweden-based non-profit organization founded in 2023 and headquartered in Mölndal. The organization provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products (ATMPs), targeting biopharmaceutical companies and research organizations developing advanced therapeutics. Its stated focus is on addressing computational limitations in drug discovery and therapeutic development by integrating quantum computing capabilities with AI-enhanced workflows for computational biology.

In December 2025, CCRM Nordic — alongside its affiliate CCRM — announced a strategic quantum-biotech collaboration with IonQ (IONQ) to develop AI-enhanced workflows for advanced therapeutics. The partnership is framed around accelerating therapeutic development processes through quantum compute combined with AI, addressing pain points around drug discovery workflows requiring specialized compute infrastructure.

CCRM Nordic operates as a non-profit with 11-50 employees and no publicly disclosed pricing, revenue model, or customer list. The available source material does not provide detail on funding sources, management team, office locations beyond the Mölndal HQ, certifications, or headcount trends. Product and service specifics are not enumerated beyond the high-level ATMP commercialization and development positioning and the AI/quantum workflow collaboration with IonQ.

Short descriptiontext

CCRM Nordic is a Sweden-based non-profit providing commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products, serving biopharmaceutical and life sciences organizations developing advanced therapeutics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMölndal, Sweden
HQ citystring
Mölndal
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
advanced therapy manufacturing, cell and gene therapy, biotech commercialization services, regenerative medicine infrastructure, therapeutic development services
Industry1 code
PRIMARYHLAJAOAM
Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Advanced Therapy Manufacturing Services
No data
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CCRM Nordic provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products. The organization supports biopharmaceutical companies and research organizations in developing and scaling advanced therapeutics, integrating quantum computing capabilities with AI-enhanced workflows for computational biology and drug discovery.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Based on the available source data, no product or service information is available for CCRM Nordic. The sources provide only a loading/verification page and a news article mentioning CCRM Nordic in the context of a strategic partnership with IonQ for quantum-biotech collaboration on AI-enhanced workflows for advanced therapeutics.

Product and service1 record
1Advanced Therapy Commercialization Support
Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

CCRM Nordic and CCRM announced a quantum-biotech collaboration with IonQ to develop AI-enhanced workflows for advanced therapeutics. The partnership leverages IonQ's quantum computing capabilities combined with AI technologies to accelerate therapeutic development processes.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global life sciences services firm combining clinical, commercial, and real-world evidence capabilities. Relevant peer given CCRM Nordic's commercialization and development mandate for advanced therapeutics.

TypeBroad incumbent
Description

Global CDMO leader with a dedicated cell and gene therapies business unit. Sets the benchmark for ATMP process development and GMP manufacturing infrastructure that CCRM Nordic is building toward.

TypeEmerging player
Description

CDMO with growing cell and gene therapy service offerings and European facilities. A direct competitor for ATMP development and manufacturing contracts in Europe.

4Recipharm
TypeRegional player
Description

Swedish-headquartered CDMO with strong presence across the Nordics. Comparable as a regional ATMP-adjacent manufacturing and development services provider, though primarily a for-profit drug product CDMO.

TypeBroad incumbent
Description

Through its Patheon and Brammer Bio businesses, offers global development and manufacturing services for advanced therapies. Sets competitive pricing and capacity benchmarks for ATMP CDMOs.

TypeBroad incumbent
Description

Large global CDMO with significant cell therapy and biologics capabilities. Represents the scale and operational depth that newer entrants like CCRM Nordic must compete against for advanced therapy clients.

TypeBroad incumbent
Description

Major CRO/CDMO offering preclinical and manufacturing services relevant to ATMP developers. Overlaps with CCRM Nordic in supporting therapeutic development workflows for biopharma clients.

TypeDirect peer
Description

The parent/global entity with which CCRM Nordic shares branding and the IonQ quantum-biotech collaboration. Operates the same ATMP commercialization and development mission and provides the network from which CCRM Nordic draws its pipeline.

TypeDirect peer
Description

UK-based non-profit accelerator offering development, manufacturing, and commercialization support for cell and gene therapies. Closest functional analog to CCRM Nordic in mission and operating model.

TypeRegional player
Description

Nordic-based life sciences company focused on bioprinting, cell line development, and lab automation. Comparable as a Nordic-headquartered life sciences infrastructure provider serving advanced therapy developers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CCRM Nordic

Advanced Therapy Manufacturing Servicesccrmnordic.se

CCRM Nordic is a Sweden-based non-profit providing commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products, serving biopharmaceutical and life sciences organizations developing advanced therapeutics.

What CCRM Nordic does

CCRM Nordic is a Sweden-based non-profit organization founded in 2023 and headquartered in Mölndal. The organization provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products (ATMPs), targeting biopharmaceutical companies and research organizations developing advanced therapeutics. Its stated focus is on addressing computational limitations in drug discovery and therapeutic development by integrating quantum computing capabilities with AI-enhanced workflows for computational biology.

In December 2025, CCRM Nordic — alongside its affiliate CCRM — announced a strategic quantum-biotech collaboration with IonQ (IONQ) to develop AI-enhanced workflows for advanced therapeutics. The partnership is framed around accelerating therapeutic development processes through quantum compute combined with AI, addressing pain points around drug discovery workflows requiring specialized compute infrastructure.

CCRM Nordic operates as a non-profit with 11-50 employees and no publicly disclosed pricing, revenue model, or customer list. The available source material does not provide detail on funding sources, management team, office locations beyond the Mölndal HQ, certifications, or headcount trends. Product and service specifics are not enumerated beyond the high-level ATMP commercialization and development positioning and the AI/quantum workflow collaboration with IonQ.

CCRM Nordic firmographics

Firmographics
Name
CCRM Nordic
Website
https://ccrmnordic.se
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
CCRM Nordic is a Sweden-based non-profit providing commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products, serving biopharmaceutical and life sciences organizations developing advanced therapeutics.
Ownership category
akta.pro rank

CCRM Nordic industry classification

Industry
Product category
Advanced Therapy Manufacturing Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAJAOAM
Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)

Keywords

  • Advanced therapy manufacturing
  • Cell and gene therapy
  • Biotech commercialization services
  • Regenerative medicine infrastructure
  • Therapeutic development services

Where CCRM Nordic is headquartered

Location

Headquarters

HQ city
Mölndal
HQ country
Sweden
HQ region
Europe

Markets served

CCRM Nordic business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

CCRM Nordic product offering

Product offering

Core offering

CCRM Nordic provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products. The organization supports biopharmaceutical companies and research organizations in developing and scaling advanced therapeutics, integrating quantum computing capabilities with AI-enhanced workflows for computational biology and drug discovery.

Product overview

Based on the available source data, no product or service information is available for CCRM Nordic. The sources provide only a loading/verification page and a news article mentioning CCRM Nordic in the context of a strategic partnership with IonQ for quantum-biotech collaboration on AI-enhanced workflows for advanced therapeutics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Advanced Therapy Commercialization Support

Companies that use CCRM Nordic

Customer profile

Segments1 record

Ideal customer profiles1 record

CCRM Nordic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CCRM Nordic partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • IonQcoreStrategic or Co-development Partner · 1 December 2025CCRM Nordic and CCRM announced a quantum-biotech collaboration with IonQ to develop AI-enhanced workflows for advanced therapeutics. The partnership leverages IonQ's quantum computing capabilities combined with AI technologies to accelerate therapeutic development processes.

Recent moves1 record

Expansion highlights3 records

CCRM Nordic competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Global life sciences services firm combining clinical, commercial, and real-world evidence capabilities. Relevant peer given CCRM Nordic's commercialization and development mandate for advanced therapeutics.
  • Lonza: Global CDMO leader with a dedicated cell and gene therapies business unit. Sets the benchmark for ATMP process development and GMP manufacturing infrastructure that CCRM Nordic is building toward.
  • Thermo Fisher Scientific (Pharma Services): Through its Patheon and Brammer Bio businesses, offers global development and manufacturing services for advanced therapies. Sets competitive pricing and capacity benchmarks for ATMP CDMOs.
  • Catalent: Large global CDMO with significant cell therapy and biologics capabilities. Represents the scale and operational depth that newer entrants like CCRM Nordic must compete against for advanced therapy clients.
  • Charles River Laboratories: Major CRO/CDMO offering preclinical and manufacturing services relevant to ATMP developers. Overlaps with CCRM Nordic in supporting therapeutic development workflows for biopharma clients.

Emerging players

  • AGC Biologics: CDMO with growing cell and gene therapy service offerings and European facilities. A direct competitor for ATMP development and manufacturing contracts in Europe.

Regional players

  • Recipharm: Swedish-headquartered CDMO with strong presence across the Nordics. Comparable as a regional ATMP-adjacent manufacturing and development services provider, though primarily a for-profit drug product CDMO.
  • BICO (formerly CELLINK): Nordic-based life sciences company focused on bioprinting, cell line development, and lab automation. Comparable as a Nordic-headquartered life sciences infrastructure provider serving advanced therapy developers.

Direct peers

  • CCRM (Centre for Commercialization of Regenerative Medicine): The parent/global entity with which CCRM Nordic shares branding and the IonQ quantum-biotech collaboration. Operates the same ATMP commercialization and development mission and provides the network from which CCRM Nordic draws its pipeline.
  • Cell and Gene Therapy Catapult: UK-based non-profit accelerator offering development, manufacturing, and commercialization support for cell and gene therapies. Closest functional analog to CCRM Nordic in mission and operating model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

CCRM Nordic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CCRM Nordic leadership team

Management profile

Number of profiles

CCRM Nordic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CCRM Nordic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCRM Nordic

What does CCRM Nordic do?

CCRM Nordic provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products. The organization supports biopharmaceutical companies and research organizations in developing and scaling advanced therapeutics, integrating quantum computing capabilities with AI-enhanced workflows for computational biology and drug discovery.

Is CCRM Nordic a public or private company?

CCRM Nordic is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CCRM Nordic founded?

CCRM Nordic was founded in 2023. It employs 11 to 50 people.

Where is CCRM Nordic based?

CCRM Nordic is headquartered in Mölndal, Sweden, in the Europe region.

Who are CCRM Nordic's main competitors?

Broad incumbents on record are IQVIA, Lonza, Thermo Fisher Scientific (Pharma Services), Catalent and Charles River Laboratories. AGC Biologics is listed as an emerging player. Regional players are Recipharm and BICO (formerly CELLINK). Direct peers are CCRM (Centre for Commercialization of Regenerative Medicine) and Cell and Gene Therapy Catapult.

Does CCRM Nordic have an API?

No public API is recorded for CCRM Nordic.

What industry is CCRM Nordic in?

CCRM Nordic's product category is Advanced Therapy Manufacturing Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals